Skip to content

A clinical trial to Study the effects of two different doses of a drug clonidine with ropivacaine in patients undergoing below umbilicus surgeries

Comparison of the Effects of Clonidine in Two Different Doses as An Adjuvant to Intrathecal Hyperbaric Ropivacaine in Elective Infraumbilical Surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060067
Enrollment
62
Registered
2023-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Umesh N P
Lead Sponsor
Dr Arunkumaran D
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients aged between 18 to 60 years posted for elective infraumbilical surgeries ASA physical status grade I and II Patients willing to give informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients who are morbidly obese BMI more than 40kg/m2 Patients allergic to study anesthetic drugs Patients shorter than 150cm and taller than 180cm height Patients posted foe emergency surgeries

Design outcomes

Primary

MeasureTime frame
To compare the sensory and motor characterstics of clonidine in two different doses when added to intrathecal hyperbaric ropivacaine 0.75% in infraumbilical surgeries. To compare the duration of analgesia of clonidine in two different doses in study subjects.Timepoint: To compare the sensory and motor characterstics of clonidine in two different doses when added to intrathecal hyperbaric ropivacaine 0.75% in infraumbilical surgeries at baseline. To compare the duration of analgesia of clonidine in two different doses in study subjects upto 8hrs

Secondary

MeasureTime frame
To compare the level of sedation, perioperative hemodynamic changes, side effects such as nausea, vomiting, shivering, pruritis, respiratory depression etc in the study subjects.Timepoint: 24 hours

Countries

India

Contacts

Public ContactDr Umesh N P

Mandya institute of medical sciences

drumeshnp@gmail.com9886645947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026